GNRH1 and Ovarian cyst: In this study, the formation rate of functional ovarian cysts was 10.1% (341/3375) in patients treated with follicular-phase depot GnRH agonist, similar to the 9.3% after the luteal-phase suppression as reported by Qublan et al.